Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedJul 22, 2026
DataAggregated Company Financials
Companies13
- 7D1.7%
- 3M-3.7%
- 1Y-7.6%
- YTD-1.1%
In the last week, the Biotech industry is up 2.1%, with Poltreg up 21%. In the same time, Urteste was down 9.8%. However, the industry is down 7.9% over the past year. Looking forward, earnings are forecast to grow by 56% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 Jul 2026 | zł2.1b | zł379.4m | -zł177,622,033.00 | 29.4x | -11.6x | 5.4x |
| Fri, 19 Jun 2026 | zł2.4b | zł379.3m | -zł177,464,051.00 | 57.3x | -13.4x | 6.3x |
| Sun, 17 May 2026 | zł2.3b | zł393.9m | -zł175,464,751.00 | 72.6x | -13.2x | 5.9x |
| Tue, 14 Apr 2026 | zł1.9b | zł353.9m | -zł150,930,751.00 | 75.6x | -12.9x | 5.5x |
| Thu, 12 Mar 2026 | zł2.0b | zł416.6m | -zł146,414,978.00 | 78.5x | -13.8x | 4.8x |
| Sat, 07 Feb 2026 | zł2.0b | zł427.5m | -zł155,672,238.00 | 60.6x | -12.9x | 4.7x |
| Mon, 05 Jan 2026 | zł1.9b | zł427.5m | -zł155,672,238.00 | 46.8x | -12.3x | 4.5x |
| Wed, 03 Dec 2025 | zł2.0b | zł424.8m | -zł161,141,036.00 | 46.8x | -12.3x | 4.7x |
| Fri, 31 Oct 2025 | zł1.9b | zł394.6m | -zł166,699,765.00 | 37.6x | -11.6x | 4.9x |
| Sun, 28 Sep 2025 | zł2.0b | zł420.9m | -zł140,394,812.00 | 42.8x | -14.2x | 4.7x |
| Tue, 26 Aug 2025 | zł2.1b | zł403.5m | -zł140,003,812.00 | 45.8x | -14.7x | 5.1x |
| Thu, 24 Jul 2025 | zł2.1b | zł401.8m | -zł140,766,468.00 | 32x | -14.6x | 5.1x |
| Sat, 21 Jun 2025 | zł2.0b | zł407.3m | -zł142,213,468.00 | 31.5x | -14.2x | 5x |
| Mon, 19 May 2025 | zł2.1b | zł427.5m | -zł110,921,634.00 | 51.5x | -19.3x | 5x |
| Wed, 16 Apr 2025 | zł2.0b | zł438.8m | -zł95,426,193.00 | 29.8x | -20.9x | 4.6x |
| Fri, 14 Mar 2025 | zł2.0b | zł438.6m | -zł94,885,631.00 | 30x | -21x | 4.5x |
| Sun, 09 Feb 2025 | zł2.0b | zł438.8m | -zł94,289,269.00 | 42.2x | -21.5x | 4.6x |
| Tue, 07 Jan 2025 | zł2.0b | zł408.7m | -zł84,434,269.00 | 41.3x | -23.1x | 4.8x |
| Thu, 05 Dec 2024 | zł1.9b | zł409.7m | -zł84,434,269.00 | 38.3x | -22.5x | 4.6x |
| Sat, 02 Nov 2024 | zł2.1b | zł409.6m | -zł91,994,969.00 | 62.4x | -22.8x | 5.1x |
| Mon, 30 Sep 2024 | zł2.1b | zł439.7m | -zł53,848,969.00 | 61.9x | -38.8x | 4.8x |
| Wed, 28 Aug 2024 | zł2.2b | zł445.0m | -zł63,393,784.00 | 65.1x | -34.4x | 4.9x |
| Fri, 26 Jul 2024 | zł2.1b | zł444.2m | -zł64,230,755.00 | 73.5x | -33.1x | 4.8x |
| Sun, 23 Jun 2024 | zł2.1b | zł444.3m | -zł95,946,755.00 | 71x | -21.7x | 4.7x |
| Tue, 21 May 2024 | zł2.3b | zł438.3m | -zł94,485,228.00 | 71x | -23.9x | 5.2x |
| Thu, 18 Apr 2024 | zł2.3b | zł437.8m | -zł72,667,007.00 | 52.6x | -31.5x | 5.2x |
| Sat, 16 Mar 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 61.6x | -30.5x | 4.9x |
| Mon, 12 Feb 2024 | zł2.4b | zł459.9m | -zł74,255,671.00 | 123.7x | -31.9x | 5.1x |
| Wed, 10 Jan 2024 | zł2.8b | zł499.9m | -zł66,755,911.00 | 90.8x | -41.8x | 5.6x |
| Fri, 08 Dec 2023 | zł2.7b | zł499.9m | -zł66,755,911.00 | 89.1x | -39.8x | 5.3x |
| Sun, 05 Nov 2023 | zł2.7b | zł511.7m | -zł63,340,678.00 | 46x | -42.4x | 5.2x |
| Tue, 03 Oct 2023 | zł2.7b | zł518.4m | -zł60,858,678.00 | 48.2x | -44.4x | 5.2x |
| Thu, 31 Aug 2023 | zł2.8b | zł520.3m | -zł43,292,668.00 | 49.5x | -64.6x | 5.4x |
| Sat, 29 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 52.9x | -68x | 5.5x |
Price to Earnings Ratio
-68x
Current Industry PE
- Investors are relatively neutral on the Polish Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 10% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 0.32% | |
| Healthcare | -0.69% | |
| Biotech | 1.66% | |
| Biotech | 1.66% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PTG Poltreg | zł23.50 | 21.1% +zł24.3m | -26.1% | PB3.8x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł75.40 | 3.4% +zł15.9m | 84.4% | PS201.1x | |
| SCS Stem Cells Spin | zł0.52 | 25.6% +zł4.3m | 83.9% | PS326.6x | |
| RDG Read-Gene | zł4.86 | 4.5% +zł2.5m | -6.9% | PE29.4x | |
| BCX Bioceltix | zł92.30 | 0.3% +zł1.7m | -13.6% | PB7.6x |